Breaking News Instant updates and real-time market news.

MRTX

Mirati Therapeutics

$63.81

-1.4 (-2.15%)

06:37
04/17/19
04/17
06:37
04/17/19
06:37

Mirati Therapeutics initiated with a Neutral at JPMorgan

JPMorgan analyst Anupam Rama started Mirati Therapeutics with a Neutral rating and $72 price target. The value for the company's broader pipeline is already somewhat reflected in the shares at current levels, Rama tells investors in a research note. Further, "value-creating catalysts" are more skewed to the second half of 2019 and beyond, the analyst adds.

MRTX Mirati Therapeutics
$63.81

-1.4 (-2.15%)

03/04/19
SBSH
03/04/19
DOWNGRADE
Target $77
SBSH
Neutral
Mirati Therapeutics downgraded to Neutral from Buy at Citi
Citi analyst Yigal Nochomovitz downgraded Mirati Therapeutics to Neutral from Buy despite raising raising his price target for the shares to $77 from $66. The analyst continues to have "well above-average" expectations for Mirati's KRAS G12C inhibitor MRTX849, "even taking the unusual step" of raising his probability of success to 25% ahead of any Phase 1 data. However, the stock is now up 70% year-to-date and is already ascribing a ~25% probability of success to MRTX849, Nochomovitz tells investors in a research note. As such, he prefers "booking a winner for now."
03/04/19
CANT
03/04/19
INITIATION
CANT
Neutral
Mirati Therapeutics initiated with a Neutral at Cantor Fitzgerald
03/05/19
CANT
03/05/19
INITIATION
Target $66
CANT
Neutral
Mirati Therapeutics initiated with a Neutral at Cantor Fitzgerald
Cantor Fitzgerald analyst Varun Kumar last night started Mirati Therapeutics with a Neutral rating and $66 price target. Current consensus estimates reflect high expectations around the novel KRASi asset, and do not fully appreciate potential clinical, regulatory and commercial risks associated with the company's lead asset sitravatinib, Kumar tells investors in a research note.
03/25/19
FBCO
03/25/19
INITIATION
Target $85
FBCO
Outperform
Mirati Therapeutics initiated with an Outperform at Credit Suisse
Credit Suisse analyst Michael Morabito started coverage of Mirati Therapeutics with an Outperform rating and $85 price target. The analyst believes Mirati holds "several very promising" assets, such as its MRTX849, a highly specific inhibitor of the G12C-mutated KRAS protein, mutations in which are common in multiple cancers. With only one competing drug in clinical development, the competitive landscape is not substantial, he notes.

TODAY'S FREE FLY STORIES

YNDX

Yandex

$37.61

-0.17 (-0.45%)

08:23
04/25/19
04/25
08:23
04/25/19
08:23
Earnings
Yandex reports Q1 EPS 16c, consensus 26c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

LEN

Lennar

$52.63

0.17 (0.32%)

08:23
04/25/19
04/25
08:23
04/25/19
08:23
Conference/Events
Lennar management to meet with KeyBanc »

Visit with management at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

ASPS

Altisource

$23.68

-0.08 (-0.34%)

08:22
04/25/19
04/25
08:22
04/25/19
08:22
Earnings
Altisource reports Q1 adjusted EPS 48c vs. 48c a year ago »

Altisource Portfolio…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

FB

Facebook

$182.64

-1.13 (-0.61%)

08:21
04/25/19
04/25
08:21
04/25/19
08:21
Recommendations
Facebook analyst commentary at Wedbush »

Facebook price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 30

    May

  • 03

    Jun

$DJT

DJ Transportation Average

$0.00

(0.00%)

08:21
04/25/19
04/25
08:21
04/25/19
08:21
Technical Analysis
DJ Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UTL

Unitil

$54.18

0.43 (0.80%)

08:20
04/25/19
04/25
08:20
04/25/19
08:20
Earnings
Unitil reports Q1 EPS $1.78 with items, consensus $1.25 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

HMI

Huami

$11.05

-1.355 (-10.93%)

08:20
04/25/19
04/25
08:20
04/25/19
08:20
Syndicate
Huami 7.93M share Secondary priced at $9.75 »

Morgan Stanley, Credit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

$DJU

DJ Utility Average

$0.00

(0.00%)

08:20
04/25/19
04/25
08:20
04/25/19
08:20
Technical Analysis
DJ Utility Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSIC

Henry Schein

$64.15

0.92 (1.46%)

08:20
04/25/19
04/25
08:20
04/25/19
08:20
Hot Stocks
Henry Schein, MindChild Medical announce distribution, supply agreement »

Henry Schein Medical, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

  • 22

    May

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

08:20
04/25/19
04/25
08:20
04/25/19
08:20
Technical Analysis
Dow Jones Industrial Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IYT

iShares Transportation Average

$199.53

1.71 (0.86%)

08:20
04/25/19
04/25
08:20
04/25/19
08:20
Technical Analysis
iShares Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLK

Technology Select Sector SPDR

$78.88

0.03 (0.04%)

08:19
04/25/19
04/25
08:19
04/25/19
08:19
Technical Analysis
Technology Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOGL

Alphabet Class A

$1,260.07

-10.53 (-0.83%)

08:19
04/25/19
04/25
08:19
04/25/19
08:19
Recommendations
Alphabet Class A analyst commentary at Wedbush »

Wedbush anticipates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Apr

08:19
04/25/19
04/25
08:19
04/25/19
08:19
Conference/Events
UBS leisure analyst to hold an analyst/industry conference call »

Leisure, Gaming &…

XLE

Energy Select Sector SPDR

$67.30

-1.24 (-1.81%)

08:19
04/25/19
04/25
08:19
04/25/19
08:19
Technical Analysis
Energy Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VLY

Valley National

$10.35

-0.01 (-0.10%)

08:19
04/25/19
04/25
08:19
04/25/19
08:19
Earnings
Valley National reports Q1 adj. EPS 22c, consensus 22c »

Reports Q1 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 02

    May

  • 08

    May

  • 13

    May

XLY

Consumer Discretionary Sector SPDR

$120.35

0.11 (0.09%)

08:19
04/25/19
04/25
08:19
04/25/19
08:19
Technical Analysis
Consumer Discretionary Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENTG

Entegris

$40.85

0.18 (0.44%)

08:19
04/25/19
04/25
08:19
04/25/19
08:19
Conference/Events
Entegris management to meet with Loop Capital »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    Apr

  • 02

    May

  • 28

    May

XLB

S&P Select Materials SPDR

$57.33

-0.34 (-0.59%)

08:19
04/25/19
04/25
08:19
04/25/19
08:19
Technical Analysis
S&P Select Materials SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$258.70

-5.15 (-1.95%)

08:18
04/25/19
04/25
08:18
04/25/19
08:18
Recommendations
Tesla analyst commentary at JMP Securities »

Tesla U.S. demand should…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLU

Utilities SPDR

$57.78

0.34 (0.59%)

08:18
04/25/19
04/25
08:18
04/25/19
08:18
Technical Analysis
Utilities SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLP

Consumer Staples Sector SPDR

$56.83

0.075 (0.13%)

08:18
04/25/19
04/25
08:18
04/25/19
08:18
Technical Analysis
Consumer Staples Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOW

ServiceNow

$242.41

-1.085 (-0.45%)

08:18
04/25/19
04/25
08:18
04/25/19
08:18
Recommendations
ServiceNow analyst commentary  »

ServiceNow price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    May

XLV

Health Care Select Sector SPDR

$87.22

-0.11 (-0.13%)

08:18
04/25/19
04/25
08:18
04/25/19
08:18
Technical Analysis
Health Care Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TPL

Texas Pacific Land Trust

$899.46

3.46 (0.39%)

08:18
04/25/19
04/25
08:18
04/25/19
08:18
Hot Stocks
Mission Advisors urges Texas Pacific Land shareholders to vote for Donald Cook »

Mission Advisors, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.